Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence
NCT03566290
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Development of investigational product was halted.
Conditions
Stress Urinary Incontinence
Interventions
DRUG:
GTx-024
Sponsor
GTx